
Nanomedicine Market Outlook and Forecasts 2023 – 2030
Description
Nanomedicine Market Outlook and Forecasts 2023 – 2030
Nanomedicine is an emerging field at the intersection of nanotechnology and medicine that focuses on the development and application of nanoscale materials and devices for healthcare purposes. It offers tremendous potential in revolutionizing diagnostics, drug delivery, imaging, and therapeutics, with the aim of improving patient outcomes and addressing unmet medical needs.
The global nanomedicine market is experiencing significant growth and is projected to expand at a rapid pace in the coming years. The market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in nanotechnology, growing demand for personalized medicine, and the need for targeted and efficient drug delivery systems. Additionally, the COVID-19 pandemic has highlighted the importance of nanomedicine in the development of vaccines, diagnostics, and therapeutics.
The nanomedicine market is characterized by a diverse range of products and applications. Nanoparticles, liposomes, and polymer-based drug conjugates are commonly used nanoscale materials in drug delivery systems, allowing for precise targeting, controlled release, and enhanced bioavailability of therapeutics. Nanoparticles also play a vital role in diagnostic imaging, enabling high-resolution imaging and early disease detection. Other applications include regenerative medicine, implants, and nanosensors for disease monitoring.
Nanomedicine offers immense potential to revolutionize healthcare by enabling targeted drug delivery, early disease detection, precise imaging, and personalized therapies. The nanomedicine market is poised for significant growth, driven by advancements in nanotechnology, increasing disease burdens, and the demand for improved healthcare solutions. Strategic investments, regulatory support, and technological advancements will continue to shape the nanomedicine market and drive its future growth.
This report investigates nanomedicine and nanomedicine-based products and services including nanoparticles used in nanomedicine. The report also analyzes the market factors and market challenges of nanomedicine market potential application areas, products and services. The report assesses product and services, and strategic initiatives of leading nanomedicine companies. It includes qualitative and quantitative analysis including market forecasts for 2023 through 2030.
Select Report Findings:
The nanomedicine market will reach $556.7 billion by 2030
North America will the leading nanomedicine regional market
More than 65% of nanomedicine solutions will be used in treatment
Nanomedicine will play key role in next generation diagnostics and treatment
Drug delivery will be a key application area and hence the focus of much R&D
Companies in Report:
Abbott Laboratories
Arrowhead Pharmaceuticals Inc.
Celgene Corporation (Bristol Myers Squibb)
DiaSorin S.p.A.
GE Healthcare
Gilead Sciences Inc.
Invitae Corporation (CombiMatrix)
Johnson & Johnson Services Inc.
Leadiant BioSciences Inc.
Luminex Corporation (DiaSorin Company)
MagArray Inc.
Mallinckrodt Pharmaceuticals
Merck & Co. Inc.
Nanospectra Biosciences
Novavax
Pfizer Inc.
Sanofi SA
Teva Pharmaceutical Industries Ltd
Thermo Fisher Scientific Inc. (Life Technologies)
UCB S.A.
Table of Contents
119 Pages
- 1.0 Executive Summary
- 2.0 Introduction
- 2.1 Defining Nanomedicine
- 2.2 Nanomedicine Market Drivers
- 2.3 Nanomedicine Market Challenges
- 2.4 Pandemic Impact Analysis
- 2.5 Nanomedicine Regulatory Analysis
- 2.6 Nanomedicine Value Chain Analysis
- 3.0 Nanomedicine Technology and Application Analysis
- 3.1 Nanomedicine Indication Analysis
- 3.1.1 Clinical Oncology
- 3.1.2 Infectious Diseases
- 3.1.3 Cardiovascular Diseases
- 3.1.4 Orthopaedic Diseases
- 3.1.5 Neurological Diseases
- 3.1.6 Urological Diseases
- 3.1.7 Ophthalmological Diseases
- 3.1.8 Immunological Diseases
- 3.2 Nanomedicine Application Analysis
- 3.2.1 Drug Delivery
- 3.2.2 Therapeutics
- 3.2.3 Diagnostic Imaging (In-Vitro & In-Vivo)
- 3.2.4 Anti-inflammatories
- 3.2.5 Anti-invectives & Vaccines
- 3.2.6 Regenerative Medicine
- 3.2.7 Implants
- 3.3 Nanomedicine Molecule Analysis
- 3.3.1 Nanoparticles
- 3.3.1.1 Metal & Metal Oxide Nanoparticles
- 3.3.1.2 Liposomes
- 3.3.1.3 Polymers & Polymer Drug Conjugates
- 3.3.1.4 Hydrogel Nanoparticles
- 3.3.1.5 Dendrimers
- 3.3.1.6 Inorganic Nanoparticles
- 3.3.2 Nanoshells
- 3.3.3 Nanotubes
- 3.3.4 Nanodevices
- 3.4 Regional Adoption of Nanomedicine
- 4.0 Nanomedicine Company Analysis
- 4.1 Abbott Laboratories
- 4.2 Arrowhead Pharmaceuticals Inc.
- 4.3 Celgene Corporation (Bristol Myers Squibb)
- 4.4 DiaSorin S.p.A.
- 4.5 GE Healthcare
- 4.6 Gilead Sciences Inc.
- 4.7 Invitae Corporation (CombiMatrix)
- 4.8 Johnson & Johnson Services Inc.
- 4.9 Leadient BioSciences Inc.
- 4.10 Thermo Fisher Scientific Inc. (Life Technologies)
- 4.11 Luminex Corporation (DiaSorin Company)
- 4.12 MagArray Inc.
- 4.13 Mallinckrodt Pharmaceuticals
- 4.14 Merck & Co. Inc.
- 4.15 Nanospectra Biosciences
- 4.16 Novsvax
- 4.17 Pfizer Inc.
- 4.18 Sanofi SA
- 4.19 Teva Pharmaceutical Industries Ltd
- 4.20 UCB S.A.
- 5.0 Nanomedicine Market Analysis and Forecasts 2023 – 2030
- 5.1 Global Nanomedicine Market 2023 – 2030
- 5.1.1 Global Nanomedicine Market by Modality
- 5.1.2 Global Nanomedicine Market by Application
- 5.1.3 Global Nanomedicine Market by Indication
- 5.1.4 Global Nanomedicine Market by Molecule Type
- 5.1.4.1 Global Nanomedicine Molecule Market by Nanoparticles Type
- 5.1.5 Global Nanomedicine Market by Region
- 5.1.5.1 North America Nanomedicine Market by Country
- 5.1.5.2 Europe Nanomedicine Market by Country
- 5.1.5.3 APAC Nanomedicine Market by Country
- 5.1.5.4 MEA Nanomedicine Market by Country
- 5.1.5.5 Latin America Nanomedicine Market by Country
- 5.2 Regional Nanomedicine Market 2023 – 2030
- 5.2.1 North America Nanomedicine Market: Application, Indication and Molecule
- 5.2.2 Europe Nanomedicine Market: Application, Indication, and Molecule
- 5.2.3 APAC Nanomedicine Market: Application, Indication, and Molecule
- 5.2.4 MEA Nanomedicine Market: Application, Indication, and Molecule
- 5.2.5 Latin America Nanomedicine Market: Application, Indication, and Molecule
- 6.0 Conclusions and Recommendations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.